FDA Inspection
S&B Pharma LLCS&B Pharma LLC – FDA Inspection, Mar 16, 2018
Record Details
This FDA Inspection record concerns S&B Pharma LLC, with an inspection on March 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Karen M. Montgomery (Company Rep)
- Srinivas Chennamaneni (Issuing Officer)
View Company Profile
ID · 9d542333-9374-409a-93d6-381f4b1aa795
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1047928
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of S&B Pharma LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 17, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 6, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 5, 2019 | Not classified | Kansas City District Office | Generic Drug Evaluation |
| October 27, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for S&B Pharma LLC
- FDA Inspection 1172319 - 2022-06-17
- FDA Inspection 1121238 - 2020-02-06
- FDA Inspection 1078320 - 2019-02-05
- FDA Inspection 1031001 - 2017-10-27
- FDA Inspection 915801 - 2015-02-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.